These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 18414385)

  • 1. The endocannabinoid system in brain reward processes.
    Solinas M; Goldberg SR; Piomelli D
    Br J Pharmacol; 2008 May; 154(2):369-83. PubMed ID: 18414385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoid tone versus constitutive activity of cannabinoid receptors.
    Howlett AC; Reggio PH; Childers SR; Hampson RE; Ulloa NM; Deutsch DG
    Br J Pharmacol; 2011 Aug; 163(7):1329-43. PubMed ID: 21545414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoid system and pain.
    Guindon J; Hohmann AG
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):403-21. PubMed ID: 19839937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Masturbation to Orgasm Stimulates the Release of the Endocannabinoid 2-Arachidonoylglycerol in Humans.
    Fuss J; Bindila L; Wiedemann K; Auer MK; Briken P; Biedermann SV
    J Sex Med; 2017 Nov; 14(11):1372-1379. PubMed ID: 29110806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization.
    Thiemann G; van der Stelt M; Petrosino S; Molleman A; Di Marzo V; Hasenöhrl RU
    Behav Brain Res; 2008 Mar; 187(2):289-96. PubMed ID: 17988751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoid biosynthesis and inactivation, from simple to complex.
    Muccioli GG
    Drug Discov Today; 2010 Jun; 15(11-12):474-83. PubMed ID: 20304091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoid system involvement in brain reward processes related to drug abuse.
    Solinas M; Yasar S; Goldberg SR
    Pharmacol Res; 2007 Nov; 56(5):393-405. PubMed ID: 17936009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing roles of CB
    Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA
    Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area.
    Mátyás F; Urbán GM; Watanabe M; Mackie K; Zimmer A; Freund TF; Katona I
    Neuropharmacology; 2008 Jan; 54(1):95-107. PubMed ID: 17655884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.
    Ellgren M; Artmann A; Tkalych O; Gupta A; Hansen HS; Hansen SH; Devi LA; Hurd YL
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):826-34. PubMed ID: 18674887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.
    Gertsch J
    Planta Med; 2008 May; 74(6):638-50. PubMed ID: 18275004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.
    Vlachou S; Nomikos GG; Panagis G
    Psychopharmacology (Berl); 2006 Oct; 188(3):293-305. PubMed ID: 16953388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid signaling mediates oxytocin-driven social reward.
    Wei D; Lee D; Cox CD; Karsten CA; Peñagarikano O; Geschwind DH; Gall CM; Piomelli D
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):14084-9. PubMed ID: 26504214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine.
    González S; Cascio MG; Fernández-Ruiz J; Fezza F; Di Marzo V; Ramos JA
    Brain Res; 2002 Nov; 954(1):73-81. PubMed ID: 12393235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoids: synthesis and degradation.
    Di Marzo V
    Rev Physiol Biochem Pharmacol; 2008; 160():1-24. PubMed ID: 18481028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anandamide: an update.
    Smita K; Sushil Kumar V; Premendran JS
    Fundam Clin Pharmacol; 2007 Feb; 21(1):1-8. PubMed ID: 17227440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake.
    Matias I; Bisogno T; Di Marzo V
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S7-S12. PubMed ID: 16570107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the endocannabinoid system by lipid rafts.
    Dainese E; Oddi S; Bari M; Maccarrone M
    Curr Med Chem; 2007; 14(25):2702-15. PubMed ID: 17979719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoids regulate the migration of subventricular zone-derived neuroblasts in the postnatal brain.
    Oudin MJ; Gajendra S; Williams G; Hobbs C; Lalli G; Doherty P
    J Neurosci; 2011 Mar; 31(11):4000-11. PubMed ID: 21411643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.